Jun Wang
Zhengzhou University
6 Papers
Jun Wang is an academic researcher from Zhengzhou University. The author has contributed to research in topics: Gene & Cancer. The author has an hindex of 3, co-authored 5 publications.
Chat about Author
Papers
Down-regulation of miR-210-3p encourages chemotherapy resistance of renal cell carcinoma via modulating ABCC1.
TL;DR: It is confirmed that down-regulation of miR-210-3p increased ABCC1 expression, thereby enhancing the MRP-1-mediated multidrug resistance of RCC cells.
Bioinformatics Analysis of GFAP as a Potential Key Regulator in Different Immune Phenotypes of Prostate Cancer.
TL;DR: Glial fibrillary acidic protein (GFAP) might serve as a key hub gene within the genetic and epigenetic regulatory networks in prostate cancer and may be a potential biomarker for both PC diagnosis and prognosis.
Integrated Analyses Reveal Potential Functional N6-Methyladenosine-Related Long Noncoding RNAs in Adrenocortical Adenocarcinoma
Yafei Ding,Tao Wang,X Ding,Xiang Li,Zhenlin Huang,Zhankui Jia,Jun Wang,Jinjian Yang +7 more
TL;DR: It is demonstrated that these 4 m6A-related long-noncoding RNAs (lncRNAs) perform integral functions in the tumor immune microenvironment, and also revealed the possibility of using these lnc RNAs to guide the development of prognostic classifications and therapy approaches for ACC patients.
2
Erythropoietin Attenuates the Memory Deficits in Aging Rats by Rescuing the Oxidative Stress and Inflammation and Promoting BDNF Releasing
Zhankui Jia,Rui Xue,Shengli Ma,Jingjing Xu,Si Guo,Songchao Li,Erwei Zhang,Jun Wang,Jinjian Yang +8 more
TL;DR: It is reported that supplements with exogenous erythropoietin (EPO) for 4 weeks could partially rescue the spatial and fear memory impairments in aged rats and restores the mRNA and protein levels of brain-derived neurotrophic factor (BDNF), the critical neurotropic factor for synaptic plasticity and memory.
Single-plane retroperitoneoscopic adrenalectomy: a new operative procedure for benign adrenal disease.
TL;DR: Single-plane retroperitoneoscopic adrenalectomy is feasible, safe, and effective in the treatment of adrenal masses <5 cm in size and provides a shorter operation time and better pain control than anatomical Retroperitoneal Adrenalectomy, especially in obese patients.